Eden Biodesign signs marketing services agreement with human genome sciences
New alliance will increase Human Genome Sciences' global marketing reach for large scale cGMP manufacturing services and provides a seamless range of services for clients from process development to 20,000L scale production
"This alliance is particularly significant for Eden Biodesign and we are delighted that such a prestigious company as Human Genome Sciences has recognised Eden Biodesign's technical excellence, global marketing reach and strong track record" commented Dr. Crawford Brown, Chief Executive Officer of Eden Biodesign. "In addition to our process development and clinical scale cGMP production services, our growing portfolio of successful clients may now also have seamless access to Human Genome Sciences' world leading expertise in late-stage process development and state-of-the-art large scale production facilities as their products progress towards, and in to, commercial launch".
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.